Drug Pipeline

Capsaicin 8% Patch Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
4
Recruiting
2
Phase 3
4
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-22 NCT07602387 Chemotherapy Induced Peripheral Neuropathy by Taxanes and Capsaicin 8%. Recruiting
Active Studies by Phase
Phase 3
2
Phase 2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06023706 Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia. Coccyx Disorder Recruiting
NCT05840562 Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced… Chemotherapy-induced Peripheral Neuropathy Recruiting
Phase 2
NCT06807164 Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain… Post-Mastectomy Neuropathic Pain Syndrome Recruiting
Not specified
NCT07602387 Chemotherapy Induced Peripheral Neuropathy by Taxanes and Capsaicin 8%. Patients With Taxane-induced Chronic Neuropathic Pain Recruiting
Sponsors Running Capsaicin 8% Patch Trials
Institut Cancerologie de l'Ouest (1) Nantes University Hospital (1) Centre Oscar Lambret (1) Hospital Ambroise Paré Paris (1)
Get alerts when Capsaicin 8% Patch trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free